Elevated urinary albumin excretion (UAE) is a predictor of the development of nephropathy and cardiovascular mortality. To study whether genetic factors may determine UAE, we examined familial aggregation of UAE in 96 large multigenerational pedigrees ascertained for type 2 diabetes. A total of 1,269 subjects had UAE measured as the urinary albumin-to-creatinine ratio (ACR). This included 630 subjects with type 2 diabetes and 639 subjects without diabetes. A significant correlation (Spearman's correlation 0.34, P < 0.001) was found between the median ACR values determined separately in nondiabetic and diabetic members of the same family. To determine whether this familial aggregation of ACR could be explained by the transmission of 1 or more major genes and thus be suitable for gene mapping studies, segregation analyses were performed. In these analyses, ACR was modeled as a continuous trait with the inclusion of age, sex, and duration of diabetes as covariates. Likelihood ratio tests were performed to test competing hypotheses, and Akaike's information criterion was used to determine the most parsimonious models. The Mendelian model with multifactorial inheritance was supported more strongly than Mendelian inheritance alone. These analyses suggested that the best model for ACR levels was multifactorial with evidence for a common major gene. When the analyses were repeated for diabetic subjects only, the evidence for Mendelian inheritance was improved, although a single major locus with additional multifactorial effects was more strongly supported. The results from the current study suggest that levels of UAE are determined by a mixture of genes with large and small effects as well as other measured covariates, such as diabetes.
U
rinary albumin excretion (UAE) elevated into the range diagnosed as macroalbuminuria or proteinuria is the hallmark of diabetic nephropathy (1, 2) . In diabetic individuals, even slight elevation of UAE into the range considered microalbuminuria is a predictor of the development of the more advanced stages of diabetic nephropathy as well as of an increased risk of death due to cardiovascular complications (3) (4) (5) (6) (7) . The latter seems to be true in nondiabetic subjects as well (8, 9) . UAE is most conveniently assessed in diabetic and nondiabetic subjects by the albuminto-creatinine ratio (ACR) in random urine specimens (10) (11) (12) (13) .
Recently, we have demonstrated that ACR is heritable in families with type 2 diabetes, even when the effects of age, sex, duration of diabetes, obesity, and blood pressure are included as covariates (14) . Furthermore, ACR and blood pressure appeared to be correlated genetically, suggesting a common underlying genetic architecture for the 2 traits, whereas their variability that could be attributed to common family environment was negligible. In addition, the strength of the genetic influence on these traits (ACR and systolic and diastolic blood pressure) was increased when the analyses were restricted to diabetic subjects (14) .
To determine whether variation in ACR suggests a role for major gene effects, segregation analysis of the ACR in families with type 2 diabetes was performed. These families were ascertained for type 2 diabetes, not for nephropathy, so that the inferences concerning support for a major gene for ACR would be unbiased. Furthermore, the pedigrees used for the analyses were large and highly informative. Because the evidence for genetic effects was derived from the transmission of ACR between relatives, the increased number of relationships in large pedigrees provides greater power than nuclear families. Should the genetic control of ACR be consistent with that of a single major gene or a major gene with other (multifactorial) contributions, the likelihood of identifying genes contributing to ACR will be increased. The present analysis, therefore, was performed to determine whether segregation of a major gene could account for the familial aggregation of ACR in type 2 diabetic families, with allowance for the effects of age, sex, and duration of diabetes.
The screening criteria used for the original family collection were as follows: 1) a proband and at least 1 sibling with type 2 diabetes, 2) ≥3 generations affected by diabetes, and 3) unilineal transmission of diabetes (diabetes entering the family on 1 side only). Diabetes was considered type 2 diabetes if hyperglycemia was managed for 2 years without insulin. The primary aim of recruitment was to select families enriched for type 2 diabetes, diagnosed before 35 years of age for early-onset type 2 diabetes, or between 36 and 59 years of age for middle-age onset of type 2 diabetes.
Efforts to recruit families included several approaches. Approximately 7,500 patients treated at the Joslin Diabetes Center who had diabetes diagnosed before 60 years of age were screened, advertisements were placed in journals targeted to people with diabetes, and advertisements were sent to diabetes educators. These efforts yielded ~2,000 families for further screening. Through telephone calls and correspondence, we determined family eligibility, willingness of family members to participate in a genetic study, and the size of the pedigree. So far, 106 multigenerational families with a dominant pattern of inheritance of type 2 diabetes have been identified and examined. To increase genetic homogeneity, 10 minority families (5 Hispanic, 4 African-American, and 1 Pacific Islander) were not included in the present study, leaving 96 Caucasian families for analysis.
After written consent to participate was obtained, family members living in New England were examined by trained family recruiters. Members of eligible families living in other parts of the U.S. or Canada were examined by nurses or phlebotomists in local medical facilities. Examinations were performed in the fasting state and included collection of peripheral blood, physical examination, and completion of medical and family history questionnaires. Each individual provided a random urine sample (not first void) for determination of the ACR. The study protocol and informed consent procedures were approved by the Human Subjects Committee of the Joslin Diabetes Center. Laboratory methods and diagnosis. Fasting blood was drawn for blood glucose determination and other biochemical measurements. Nondiabetic individuals and those diabetic individuals treated with oral agents or diet had an additional blood sample drawn 2 h after an oral challenge with 75 g of glucose for blood glucose determination.
Diabetes was diagnosed if 1) an individual was treated with insulin or oral agents, 2) results of the oral glucose tolerance test (OGTT) met World Health Organization (WHO) criteria for diabetes, or 3) the level of HbA 1c was >7.0% (normal <6.0%) in individuals who declined the OGTT (15, 16) .
Individuals who did not meet any of these criteria for a diagnosis of diabetes but were not normoglycemic according to WHO criteria were classified as having impaired glucose tolerance (n = 67). Also, women who were normoglycemic at the time of examination but had a clinically documented history of diabetes during pregnancy were considered as having gestational diabetes (n = 15). Both of these groups were considered as type 2 diabetes in the primary analysis described here. In a secondary analysis, both groups were excluded.
Methods for measuring urinary levels of albumin and creatinine for determinations of ACR as an index of UAE have been described previously (13) . Briefly, a random urine sample (not a first void) obtained at the time of examination was first assayed by Multistix (Bayer, Diagnostics Division, Elkhart, IN), which was read by an optical scanner. Urine samples with a Multistix reading ≥2+ (albumin >100 mg/dl) were considered overtly albuminuric, and the albumin and creatinine concentrations were not assayed. All others were assayed for albumin and creatinine concentrations. Albumin concentration was measured by immunonephelometry on a BN100 with the N Albumin Kit (Dade Behring, Marburg, Germany) for serum albumin and a manufacturer-supplied protocol designed specifically for the low concentration of albumin found in urine. The coefficients of variation were <2% intra-assay and <4% interassay. Urine creatinine concentrations were performed by alkaline picric colorimetry (modified Jaffe reaction) on a Synchron CX5 (Beckman Instrumentation, Brea, CA). The ratio of concentrations of albumin (µg) to creatinine (mg) in random urine specimens was used as an index of UAE. ACR values expressed in µg/mg approximate the numeric values of the corresponding albumin excretion rate (AER) measured in timed urine collections and expressed in µg/min. A precise means to convert an ACR to an AER were published previously (13) . Arbitrary values of the ACR were assigned to the 24 diabetic individuals with overt albuminuria (Multistix ≥2+) and the 16 diabetic individuals with end-stage renal disease. For this purpose, we randomly selected a value from the distribution of ACR values that have been determined on urine samples from 120 patients who gave a 2+ Multistix result (25th percentile, 1,077 µg/mg; 50th percentile, 2,195 µg/mg; and 75th percentile, 3,562 µg/mg). For the 24 family members with overt proteinuria, we randomly selected a result from the whole distribution. For the 16 family members with end-stage renal disease, we randomly selected a value from the upper half of that distribution so that, on average, their values would be higher than the values for those with overt albuminuria.
The hypertension status of all examined individuals was determined. Hypertension was considered present if the blood pressure measured at the examination was ≥140 mmHg systolic or ≥90 mmHg diastolic, or the individual was treated with antihypertensive drugs, including ACE inhibitors.
Age was calculated as the difference between the year of birth and the year of examination, and duration of diabetes was calculated as the difference between the year of diabetes diagnosis and the year of examination. Duration of diabetes for patients with impaired glucose tolerance or gestational diabetes was considered to be 0 years. Data analysis. Differences between group means were tested by unpaired t test. ACRs were transformed to the logarithm (base 10) for statistical analysis and designated logACR. Because the asymmetry of the distribution of logACR in the diabetic family members persisted after the transformation, the nondiabetic and diabetic members of the families were characterized by their medians rather than their means.
Because antihypertensive treatment and treatment with ACE inhibitors, specifically, may change ACR levels, we examined first their effects on the heritability of logACR in our family collection. A detailed description of the variance components analysis used for this purpose is published elsewhere (14) . The heritability for logACR in the total family collection was 0.243 ± 0.048 when age, sex, diabetes status, and diabetes duration were included as covariates (all of them had significant impact on the heritability). It changed to 0.251 ± 0.047 if antihypertensive treatment was added to the previously included covariates and changed to 0.242 ± 0.046 if ACE inhibitor usage was added as another covariate. All of these changes in heritability are very small: <20% of the standard error. Thus, we concluded that heritability of logACR in our family collection was not altered by including antihypertensive treatment in the analysis. For this reason, this covariate was not considered in the segregation analyses. Segregation analysis. Families were identified because of the occurrence of multiple cases of type 2 diabetes, and study families were selected for examination before we had any knowledge of the nephropathy status of any family member. Thus, ascertainment of ACR should be independent of the occurrence of nephropathy. Families were typically 3 generations in size and contained large numbers of first-and second-degree relationships with ACR measurements. Using the complete pedigrees rather than partitioning pedigrees into nuclear families allows for more information and greater power to determine major gene effects, if present.
Segregation analysis was performed on the ACR as a continuous trait (BoxCox transformed). The general transmission probability model using the logistic distribution of Bonney (17), as implemented in the Regressive Models for Continuous Traits (REGC) program of Statistical Analysis for Genetic Epidemiology (S.A.G.E.) (18), was used to analyze the data under class A model structure. Mendelian inheritance, if present, was assumed to be established through a single autosomal locus with two alleles, A and B. The model assumes that up to 3 types of individuals, labeled AA, AB, and BB, exist, with the frequencies defined in terms of the allele frequencies q A (allele A) and q B (= 1 -q A ; allele B). The means of the underlying distributions are denoted as µ AA , µ AB , and µ BB , with assumed equal genotypic variances ( 2 m ). Each transmission probability ( u ) represents the probability that a parent with genotype u transmits the allele A to offspring. For u = AA, AB, and BB, the transmission probabilities are AA , AB , and BB , respectively. Under Mendelian inheritance, AA = 1.0, AB = 0.5, and BB = 0. It is assumed that transmission from 2 parents occurs independently, corresponding to random mating. Residual correlations represent the excess variation due to multifactorial effects (that component of the familial aggregation that is not accounted for by a major locus effect) as denoted by spousal correlations ( FM ), mother-offspring correlations ( MO ), and father-offspring correlations ( FO ). For the spousal correlations to be estimated, both parents need to have ACR measurements; fortunately, ACR can be measured in both diabetic and nondiabetic individuals.
Evaluation of evidence for a major gene is performed by adherence to 3 criteria: 1) rejection of the hypothesis of "no major effect"; 2) rejection of the hypothesis of "no transmission" of the major effect; and 3) failure to reject the hypothesis of "Mendelian transmission." Models that were fit to the assembled data included the "no major effect" model (multifactorial [Mf] only), a "no transmission" model (Mf and commingled), a Mendelian model, a Mendelian model with multifactorial effects, and 2 models that include estimation of transmission probabilities (one estimating only AB , the other estimating all 's).
Twice the difference in the log likelihood (-2lnL) of the data under the hypothesis of interest was compared with that under an alternative model. The resulting statistic is assumed to have a 2 distribution with degrees of freedom determined by the difference in the number of estimated parameters of the 2 models. Because the inclusion of covariate information may make the assumption of hierarchy of models untenable, the Akaike's information criterion (AIC) (19) was used to compare results of models, defined by -2lnL + 2p, where p represents the number of estimated parameters. The model with the minimum AIC would be considered the most parsimonious model.
RESULTS
The characteristics of the families used for this study are shown in Table 1 . In the 96 families, 1,520 individuals were willing to participate in genetic studies. Of these, 1,269 have been examined, and their diabetes status and renal status have been determined. Examinations of the remaining 251 individuals had not been completed as of the time of this analysis, mainly because of difficulties in arranging for the examination in a facility local to where the subjects live. Almost half of the examined subjects (630) have type 2 diabetes, and 639 have normal glucose tolerance. On average, 6.6 individuals (range 3-14) with diabetes and 6.7 individuals (1-24) without diabetes were examined per family. In all families, members of ≥2 generations were examined. Type 2 diabetes was predominantly early onset (median age at diagnosis of diabetes in the family <35 years) in 45 families and predominantly middle-age onset (median age at diagnosis of diabetes in the family between 36 and 60 years) in 51 families.
ACR data from all examined members of these families, irrespective of diabetes status, were used in the analyses. Descriptive clinical characteristics of these individuals are shown in Table 2 according to diabetes status. Slightly fewer male than female subjects are represented (43 and 46% of the diabetic and nondiabetic members, respectively). The mean age of nondiabetic individuals at the time of examination was 45 ± 18 years compared with 52 ± 18 years for those with diabetes (P < 0.0001). Their mean age at diagnosis of diabetes was 38 ± 18 years, giving a mean diabetes duration of 14 years. At the time of examination, 50% of the diabetic members were treated with insulin, 30% with oral agents, and 20% with diet (not including the 67 individuals with impaired glucose tolerance and 15 with gestational diabetes). Among the individuals without diabetes, 28% had hypertension and 7% were treated with antihypertensive medications. Among individuals with diabetes, 50% had hypertension and 28% were treated with antihypertensive medications. Figure 1 shows the distribution of logACR in examined members of the 96 families according to diabetes status. In those without diabetes, the distribution of logACR is unimodal (median 6 µg/mg) with a small proportion (5%) having ACR values between 42 and 4,200 µg/mg (Fig. 1 insert) . In those with diabetes, the logACR distribution is dramatically different. In individuals with diabetes, only 28% had ACR values below the 50th percentile for those without diabetes, 47% had values between the median and 95th percentile for those without diabetes, and 25% had values above the 95th percentile for those without diabetes. The small peak between logACR 3.3 and 4.0 represents individuals with overt proteinuria or end-stage renal disease (ESRD).
To examine the relationship between ACR in nondiabetic and diabetic individuals in the same family, median values of the logACR were determined separately for the diabetic and nondiabetic members of each family. Data are n or means ± SD. of the families according to the respective medians. For the nondiabetic members of the families, the distribution was quite symmetrical and none was above the normoalbuminuria range (logACR <1.5). However, the distribution for the diabetic members was strikingly different depending on whether their nondiabetic relatives were in the lower or upper half of the range for normoalbuminuria. If the median for the nondiabetic family members was in the upper range of normoalbuminuria, the median for their diabetic relatives was frequently elevated above the range for normoalbuminuria. In contrast, if the median for the nondiabetic members was in the lower range of normoalbuminuria, very few families had an elevated value among their diabetic members. Overall, the Spearman correlation between median values of logACR in diabetic and nondiabetic family members was 0.34 (P < 0.001).
We examined familial clustering of ACR values more precisely in a segregation analysis that takes into consideration the specific genetic relationships between the diabetic and nondiabetic relatives in these extended pedigrees and can adjust for potentially confounding variables such as sex, age, diabetes status, and duration of diabetes. The results of this analysis for the total group are shown in Table 3 . The hypothesis of "no major effect" was assessed by the comparison of a model with multifactorial inheritance alone (Mf only), considered the null model, with 1 containing both a Mendelian major gene and multifactorial inheritance (Mf + Mendelian). The null model was rejected ( 2 = 73.30, 3 df, P < 0.001). The hypothesis of "no transmission of the major effect" was assessed by comparing the commingled model (Mf + commingling) with the model in which all transmission probabilities were estimated (Mf + 's); this hypothesis was also rejected ( 2 = 21.12, 3 df, P < 0.001). The hypothesis of "Mendelian transmission" was tested by comparing the mixed model (Mf + Mendelian) with the model in which AB was estimated (Mf + AB ); this hypothesis was not rejected ( 2 = 0.22, 1 df), because AB was estimated at 0.52, close to the value assumed by Mendelian inheritance (0.50). The hypothesis of "Mendelian transmission" was also tested by comparing the mixed Mendelian model (Mf + Mendelian) with the model in which all transmission probabilities ( AA , AB , and BB ) were estimated (Mf + 's). Because our families included large numbers of diabetic individuals, segregation analyses were also carried out only among individuals with diabetes. These analyses were performed by coding all nondiabetic individuals as having missing ACR data. Although it is recognized that this approach will reduce power by including only a portion of the available data (thereby reducing the number of genetic relationships available for inference), the models supported by the data and the parameter estimates may provide insight as to the effect of diabetes in these pedigrees.
The results of analysis of logACR in the diabetic subjects within the pedigrees are shown in Table 4 . The null hypothesis of "no major effect" (Mf only vs. Mf + Mendelian) was rejected ( 2 = 21.26, 3 df, P < 0.001). The hypothesis of "no transmission of the major effect" (Mf + commingling vs. Mf + 's) was not rejected ( 2 = 6.16, 3 df). The hypothesis of "Mendelian transmission" (Mf + Mendelian vs. Mf + AB ) was not rejected ( 2 = 0.52, 1 df), because AB was estimated at 0.46, close to the value assumed by Mendelian inheritance (0.50). The hypothesis of "Mendelian transmission" (Mf + Mendelian vs. Mf + 's) was rejected ( 2 = 14.99, 3 df, P < 0.05) due, primarily, to the deviation of AA (estimated at 0.71) from its expected value (1.00). Inspection of the AIC values for all models indicates that the model with the lowest AIC was the "Mf + 's" model (AIC = 1,277.40), the same as for the total group. Thus, within diabetic subjects, there is similar evidence for the effect of a contribution of a major locus (although clearly not the only contribution to variation in ACR).
The analysis of these same models was repeated in the group of diabetic individuals after excluding those with impaired glucose tolerance or gestational diabetes. The pattern of the results and conclusions drawn from these analyses remained identical to those that included them among the individuals with diabetes (data not shown).
The evidence for a major locus effect in the diabetic subjects is similar to that observed in the full pedigrees. The model that most completely describes the control of ACR levels in these pedigrees combines the effect of a major locus with a relatively common gene (estimated frequency 0.40) and residual genetic variation that could be due to multiple factors. Although there is strong evidence for these effects, the deviation from complete support for a major locus occurs mainly in the departure of the AA transmission probability from its expected value. This parameter estimates the probability of an individual with the AA genotype transmitting an A allele to an offspring. In this situation, the AA genotype is predicted to have a high ACR value, thus suggesting that parents with high ACR levels fail to transmit the high allele in all cases (more low ACR children than expected). These results could occur because of incomplete age adjustment, with purported A-carrying children being too young to express an increased level of ACR.
DISCUSSION
Familial clustering of nephropathy has been described many times since the first report 10 years ago, but with limited efforts to evaluate the possible modes of inheritance, if any, as a basis of genetic susceptibility (20) (21) (22) (23) (24) . Albuminuria, the hallmark of diabetic nephropathy, and its surrogate measure, the ACR, are heritable, even when other major covariates are considered. This study presents, for the first time, a formal analysis of the inheritance characteristics of the major diabetic nephropathy trait, ACR, in Caucasian families with type 2 diabetes. The analysis of ACR in these families provides evidence for a major gene contributing to the variation in UAE. This evidence is a crucial step in justifying and guiding the design of studies to map genes involved in susceptibility to diabetic nephropathy.
Despite the absence of a specific knowledge of the genetic basis of diabetic nephropathy, several groups have embarked in recent years on searches for genes for susceptibility to diabetic nephropathy (25) (26) (27) a scarcity of families with multiple affected members with advanced diabetic nephropathy because of the high mortality of these individuals. This effort has also been hampered by the lack of precision in inferences about linkage in these studies that results in the absence of accurate inheritance parameters (28, 29) .
As an alternative to searching for genes that contribute to advanced diabetic nephropathy, one may search for genes contributing to UAE, a quantitative intermediate phenotype for this complication. The strategy of attempting to map intermediate traits is a well-established approach in the effort to map hypertension or diabetes susceptibility, and this study suggests that UAE may be used similarly. The analysis of ACR in these families supports the hypothesis that there is a major gene contributing to the variation in UAE. This effect was seen even when the analysis was limited to the smaller, less powerful subset of individuals with diabetes in the families. This result further supports the existence of genes that influence UAE separately from those causing diabetes. These data also extend our previous finding of a significant heritability for ACR in the diabetic and nondiabetic members of these families (14) . The results presented here suggest that familial transmission of ACR in these families does fit well with at least 1 major gene and may be usefully pursued in family studies similar to intermediate diabetes phenotypes in genetic studies of type 2 diabetes (30).
The results here are in keeping with recent preliminary data from studies of diabetic nephropathy in the Pima Indian population. In those studies of families with type 2 diabetes, complex segregation analysis indicates that a single major gene influences overt nephropathy. In the preliminary report of these data (31), models supporting evidence of Mendelian inheritance consistently fit the data, with a common allele (frequency of 0.45) that is quite close to the frequency estimated here (0.25-0.40).
To date, there are no segregation studies regarding nephropathy in type 1 diabetes, and this situation is likely to be difficult to remedy owing to the absence of extended families with type 1 diabetes. However, in our previous work assessing the lifetime risk of diabetic nephropathy in type 1 diabetic siblings, there was an almost 50% difference between the cumulative incidence rates for siblings of proteinuric probands and for siblings of normoalbuminuric probands (21) . One interpretation of these data was that there was a major gene effect contributing to nephropathy susceptibility. Therefore, these studies, in different populations, support the idea that nephropathy susceptibility is often based on major gene effects.
It should be noted that the presence of a major gene pattern of transmission does not preclude multiple genes (each with a similar transmission pattern) contributing to the variation in ACR or the contribution of other (environmental) factors. Previous studies of nondiabetic siblings and offspring of cases with type 2 diabetes and nephropathy have also suggested that genetic factors contribute to elevated albumin excretion (32) (33) (34) . However, these studies were relatively small and, unlike the present study of UAE in extended families, they could not yield estimates of the mode of inheritance of the putative major genetic locus influencing albumin excretion, which has potential utility for gene mapping studies.
Over the last several years, many research groups have been searching for susceptibility genes for advanced diabetic nephropathy using a candidate gene approach or a genome scan (35, 36) . None of the examined candidate loci have been found to have a major effect, although some have been found to have minor effects (35, 36) . On the other hand, preliminary genome scans using affected sib-pair or discordant sib-pair study designs have identified chromosomal regions that might harbor genes with major effects on susceptibility to diabetic nephropathy. These regions include the long arm of chromosome 3 in type 1 diabetes and the long arm of chromosome 7 in type 2 diabetes (25, 26) . One may plausibly anticipate that these chromosomal regions will show even stronger linkage with ACR variability in families with diabetes, resulting in narrower critical regions on those chromosomes as well as allowing identification of chromosomal regions that have only moderate effects on susceptibility to diabetic nephropathy.
One of the limitations of this study is the availability of only 1 determination of UAE, a measure that has high intraindividual variability. This intraindividual variability, however, is likely to have increased the variation within families and reduced the power to detect a major gene effect on its variance. Given this concern, the estimates of allele frequency and transmission probabilities need to be interpreted cautiously.
Another issue is the recent evidence suggesting morphological heterogeneity of nephropathy in type 2 diabetes (37) . A corresponding heterogeneity in the determinants of the ACR level would also diminish power to identify major gene effects by segregation analysis. Although we have included duration of diabetes as a covariate (along with age and sex), we have not accounted for other correlates of ACR, such as blood pressure (38, 39) . However, given the strong genetic correlation between ACR and blood pressure, already demonstrated in this population, it is inappropriate to include blood pressure as a covariate in the segregation analysis. Blood pressure closely tracks with ACR phenotypically and, more importantly, genetically (14) .
In summary, the current findings have implications for designing studies to search for genes affecting susceptibility to diabetic nephropathy in Caucasian populations. First, the families were ascertained on the basis of diabetes, not diabetic nephropathy, so that the results of the analyses should not suffer from ascertainment bias due to selection of multiple cases of nephropathy. In addition, the pedigrees were large and highly informative for the trait being studied (ACR), with many genetic relationships available over the several generations tested. Because the ACR can be measured in individuals both with and without diabetes, the trait is an excellent quantitative characteristic. These segregation analyses suggest that a major gene effect for ACR may act in a nearly recessive manner with significant residual genetic variation. Second, genes for ACR may be detected using a standard linkage strategy that combines use of highly polymorphic markers with both model-dependent and model-independent methods. Because ACR can be considered a quantitative surrogate of nephropathy, the search for nephropathy genes can be more effective if linkage to ACR were used, since the power of the pedigrees for a highly heritable quantitative trait (ACR) will be greater than that of the same pedigrees for the dichotomous trait (nephropathy). Thus, using ACR as a quantitative surrogate trait for nephropathy, one may implement more effective study designs as well as analytical methods than one could use for diabetic nephropathy as a discrete outcome.
